Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipranavir Dose Optimization in Experienced HIV Patients
NCT00034866Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Apr 2002; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00034866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034866.